251 related articles for article (PubMed ID: 27795373)
21. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
22. The effect of sepsis upon gentamicin pharmacokinetics in neonates.
Lingvall M; Reith D; Broadbent R
Br J Clin Pharmacol; 2005 Jan; 59(1):54-61. PubMed ID: 15606440
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.
Li X; Qi H; Jin F; Yao BF; Wu YE; Qi YJ; Kou C; Wu XR; Luo XJ; Shen YH; Zheng X; Wang YH; Xu F; Jiao WW; Li JQ; Xiao J; Dong YN; Du B; Shi HY; Xu BP; Shen AD; Zhao W
Eur J Pharm Sci; 2021 Aug; 163():105868. PubMed ID: 33951483
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
25. Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.
Maksoud E; Koehl B; Facchin A; Ha P; Zhao W; Kaguelidou F; Benkerrou M; Mariani P; Faye A; Lorrot M; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378711
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis.
Gastine S; Obiero C; Kane Z; Williams P; Readman J; Murunga S; Thitiri J; Ellis S; Correia E; Nyaoke B; Kipper K; van den Anker J; Sharland M; Berkley JA; Standing JF
J Antimicrob Chemother; 2022 Feb; 77(2):448-456. PubMed ID: 35107141
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
[TBL] [Abstract][Full Text] [Related]
28. Short versus long infusion of meropenem in very-low-birth-weight neonates.
Padari H; Metsvaht T; Kõrgvee LT; Germovsek E; Ilmoja ML; Kipper K; Herodes K; Standing JF; Oselin K; Lutsar I
Antimicrob Agents Chemother; 2012 Sep; 56(9):4760-4. PubMed ID: 22733063
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
Muller AE; DeJongh J; Bult Y; Goessens WH; Mouton JW; Danhof M; van den Anker JN
Antimicrob Agents Chemother; 2007 Oct; 51(10):3720-5. PubMed ID: 17646418
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations.
van Donge T; Pfister M; Bielicki J; Csajka C; Rodieux F; van den Anker J; Fuchs A
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358294
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of gentamicin by interval and intravenous dosage adjustment based on the gestational age in Thai neonates.
Tantiprabha W; Juntarakana S; Chotinaruemol S; Rojanasthien N
J Med Assoc Thai; 2007 Dec; 90(12):2601-7. PubMed ID: 18386709
[TBL] [Abstract][Full Text] [Related]
32. Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation.
Ghoneim RH; Thabit AK; Lashkar MO; Ali AS
Ital J Pediatr; 2021 Aug; 47(1):167. PubMed ID: 34362436
[TBL] [Abstract][Full Text] [Related]
33. Dose Optimization of Gentamicin in Critically Ill Neonates.
Sridharan K; Al Jufairi M; Qader AM; Elsegai OAM
Curr Drug Metab; 2020; 21(4):270-280. PubMed ID: 32394828
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.
Fuchs A; Guidi M; Giannoni E; Werner D; Buclin T; Widmer N; Csajka C
Br J Clin Pharmacol; 2014 Nov; 78(5):1090-101. PubMed ID: 24938850
[TBL] [Abstract][Full Text] [Related]
35. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness.
Lopez SA; Mulla H; Durward A; Tibby SM
Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786
[TBL] [Abstract][Full Text] [Related]
36. [Gentamicin pharmacokinetics in term newborn: ¿Is it necessary to systematically monitor plasmatic levels?].
Telechea H; Gesuele J; Grosso P; Galarraga F; Guzzo F; Speranza N; Antúnez F; Nanni L; Giachetto G
Rev Chilena Infectol; 2016 Feb; 33(1):7-11. PubMed ID: 26965871
[TBL] [Abstract][Full Text] [Related]
37. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya.
Thomson AH; Kokwaro GO; Muchohi SN; English M; Mohammed S; Edwards G
Br J Clin Pharmacol; 2003 Jul; 56(1):25-31. PubMed ID: 12848772
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of gentamicin in South African newborns.
Botha JH; du Preez MJ; Adhikari M
Eur J Clin Pharmacol; 2003 Dec; 59(10):755-9. PubMed ID: 14566440
[TBL] [Abstract][Full Text] [Related]
40. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]